Pre-Transplant blood test may flag BK virus danger

NCT ID NCT04506060

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at 378 kidney transplant patients to see if measuring antibodies against BK virus before transplant could predict whether the virus would reactivate after surgery. Researchers used a lab-made virus-like particle to test for five different BK virus types. The goal is to help doctors identify high-risk patients and prevent kidney damage from BK virus infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify kidney transplant patients at higher risk for BK virus reactivation, allowing closer monitoring and earlier intervention.
What could go wrong: This is an observational study, not a treatment trial. It only measures antibodies before transplant and does not test any new drug or therapy. The results may not lead to changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BK VIRUS NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

BK-virus nephropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BK VIRUS NEPHROPATHY KIDNEY TRANSPLANTATION RISK FACTOR

Contacts and locations

Locations

CHU Amiens

Amiens, 80480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.